Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico

Nav

General Info

Geography

Mexico (MEX)

Coverage type

Country

Time period covered

01/2007 - 12/2009

Data type

Scientific literature

Keywords

Diagnosis, Diagnostic equipment, Health care costs, Health care expenditures, Tuberculosis

Citation

Authors

Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin R, Castañeda R, Deiss R, Garfein RS

Journal

Int J Tuberc Lung Dis

Volume

Issue

Pages

962-8

Publication year

2009

Suggested citation

Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin R, Castañeda R, Deiss R, Garfein RS. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. Int J Tuberc Lung Dis. 2009; 13(8): 962-8.

PMID

19723375

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico

Nav